MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30

$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

MariMed's total debt was $25.94M at Dec 31, 2022. For fiscal 2022 it was $25.94M, up 50.3% from the year before.

Period	Period end	Value	Change
FY2022	Dec 31, 2022	$25.94M	+50.3%
FY2021	Dec 31, 2021	$17.26M	+61.6%
FY2020	Dec 31, 2020	$10.68M	-53.8%
FY2019	Dec 31, 2019	$23.10M	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q4 FY2022	Dec 31, 2022	$25.94M	+701.7%
Q1 FY2022	Mar 31, 2022	$46.00K	-99.6%
Q4 FY2021	Dec 31, 2021	$17.26M	-14.3%
Q3 FY2021	Sep 30, 2021	$925.87K	-96.7%
Q1 FY2021	Mar 31, 2021	$3.24M	-49.6%
Q4 FY2020	Dec 31, 2020	$10.68M	-53.8%
Q3 FY2020	Sep 30, 2020	$20.15M	+520.1%
Q2 FY2020	Jun 30, 2020	$28.39M	–
Q1 FY2020	Mar 31, 2020	$6.42M	–
Q4 FY2019	Dec 31, 2019	$23.10M	–
Q3 FY2017	Sep 30, 2017	$3.25M	–